Mark McClellan, M.D., Ph.D., is currently the director of the Engelberg Center for Health Reform, senior fellow in Economic Studies and Leonard D. Schaeffer Director's Chair in Health Policy Studies at the Brookings Institution in Washington D.C., where he is actively involved in health care technology, policy and economics.
From 2004 to 2006, McClellan was administrator for the Centers for Medicare and Medicaid Services in the U.S. Department of Health and Human Services. In this position, he was responsible for administering the Medicare and Medicaid programs, including Medicare Part D, the prescription drug benefit program engendered by the Medicare Prescription Drug, Improvement, and Modernization Act.
In 2002, McClellan became commissioner for the U.S. Food and Drug Administration (FDA), following unanimous Senate confirmation. He served as FDA commissioner until 2004.
Prior to joining the FDA, McClellan served on the President's Council of Economic Advisors and was associate professor of Economics at Stanford University, associate professor of medicine at Stanford Medical School, a practicing internist and director of the Program on Health Outcomes Research at Stanford University.
McClellan was also a research associate of the National Bureau of Economic Research and a visiting scholar at the American Enterprise Institute. McClellan has twice received the Arrow Award for Outstanding Research in Health Economics.
2007 - Current (over 9 years)
Board & Advisor Roles (6)Update
|Jan 15, 2009||Xconomy - How to Survive the Downturn: Five Questions With Boston Biotech Leaders, Part 1|
CEA is charged with offering the President...